Slide 1: Executive Summary

Macroeconomic Indicators

Slide 2: GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (Jul 2013 - Dec 2013)

Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013 - Jul 2013), Exchange Rate: Half Yearly (Oct 2013 - Mar 2014)

Slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2010-11, 2011-12, 2012-13, 2013-14), FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13)

Introduction

Slide 5-6: Types of Chemotherapy drugs

Market Overview

Slide 7-9: Global Oncology Pharmaceutical Market - Overview, Market Size & Growth (2013-2018e), Indian Oncology Pharmaceutical Market - Overview, Market Size & Growth (2013-2018e), Regions with high cancer prevalence, Top 5 cancer's in India

Export-Import

Slide 10-11: Region wise Exports, Total Exports, Region wise Imports, Total Imports

Value Chain

Slide 12-13: Market Value Chain Analysis

Drivers & Challenges

Slide 14: Drivers and Challenges - Summary

Slide 15-19: Drivers

Slide 20-22: Challenges

Government Initiatives

Slide 23: Government Initiatives - Summary

Slide 24: Helping the Market to grow

Slide 25: National List of Essential Medicines (NLEM), Jan Aushadhi Stores (JAS)

Slide 26-27: cancer awareness programmes

Slide 28: Reduction in Excise Duties

Regulations

Slide 29: Licensing and registration of pharmaceuticals

Slide 30: Various other regulatory frameworks

Slide 31-33: Patent Approvals

Competitive Landscape

Slide 34: Porter's Five Forces Analysis

Slide 35: Public Trading Comparables, Top 3 Companies

Slide 36-38: Competitive Benchmarking, Key Ratios of Top 3 Companies - Operational Basis (FY 2013)

Slide 39: Competitive Benchmarking, Key Ratios of Top 3 Companies - Financial Basis (FY 2013)

Slide 40-75: Major Public Players

Slide 76-85: major Private Players

Recent Developments

Slide 86-87: Recent Developments

Strategic Recommendation

Slide 88: Strategic recommendation

Appendix

Slide 89: Key Ratios Description

Slide 90: Sources of Information

Netscribes' latest market research report titled Oncology Pharmaceutical Market in India 2014 highlights the analysis of the drivers and explains the factors for growth of the industry. Increasing number of cancer cases are the key drivers of this market. Lung, stomach, colon and breast cancer cause the maximum number of cancer deaths each year. Pharmaceutical companies are progressively increasing R&D expenditure on cancer vaccines. The growing number of patients seeking treatment for cancer has made hospitals realize that cancer treatment is an important area for growth. Gleevec, Mabthera, Iressa, Avastin, Grafeel, Soliris and Herceptin are the top selling cancer drugs in the Indian market.

Alternative therapies such as cancer gene therapy and cancer cell therapy are increasingly becoming popular in cases where conventional therapies have failed. Combination therapies are being increasingly used in cancer treatments. Some challenges faced by the industry are the internal competition between large pharmaceutical companies. Another challenge is the penetration of Oncological drugs in rural areas which is very low. Various government initiatives have been undertaken to reduce the drug prices and various tax reforms and control programs are promoting the growth of the market as well. Manufacture of generic oncology drugs will help the pharmaceutical manufacturer gain a competitive advantage over others in a highly competitive pharma market. Companies should focus on development of new molecules in order to prolong the longevity of a blockbuster drug in the market.